Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
주식 순위 #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
주가
$50.95
시가총액
$226.41B
변동 (1일)
2.58%
변동 (1년)
-26.16%
국가
DK
거래 Novo Nordisk A/S (NVO)

카테고리

Novo Nordisk A/S (NVO)의 EPS
March 2026 기준 EPS TTM: $4.36
Novo Nordisk A/S의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $4.36입니다. 2024년 말에는 회사의 EPS가 $3.16였으며, 이는 2023년의 EPS $2.76와 증가입니다.
Novo Nordisk A/S의 EPS 기록 (2000 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $4.36 20.40%
2025 $3.62 14.52%
2024 $3.16 14.42%
2023 $2.76 56.72%
2022 $1.76 10.96%
2021 $1.59 7.30%
2020 $1.48 20.24%
2019 $1.23 0.54%
2018 $1.23 -1.37%
2017 $1.24 16.81%
2016 $1.06 7.67%
2015 $0.99 20.28%
2014 $0.82 -5.24%
2013 $0.87 25.34%
2012 $0.69 31.26%
2011 $0.53 18.44%
2010 $0.44 28.33%
2009 $0.35 18.86%
2008 $0.29 9.87%
2007 $0.27 50.37%
2006 $0.18 25.27%
2005 $0.14 2.77%
2004 $0.14 13.97%
2003 $0.12 44.42%
2002 $0.08 24.70%
2001 $0.07 19.07%
2000 $0.06 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.01 290.29%
US
$42.53 875.84%
US
$9.62 120.75%
BE
$23.88 447.92%
NL
$4.36 0.04%
US